ScopusElsevier Scopus
Status
Active
Coverage
2000–present
Source type
Journal
Open access
No
CiteScore
42
SJR · SCImago
9.432
Q1 SJR quartile
H-index
455
Best quartile
Q1 · 98th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 8 / 428 | 98th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
The Lancet Oncology
The Lancet Oncology is Scopus-indexed (Q1, CiteScore 42), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 1470-2045Verify ISSN ↗1474-5488Verify ISSN ↗
Publisher: Elsevier Ltd
Scopus · Q1WoS · SCIEONOS
42
CiteScore 2025
Q1
Best quartile
2
Indexed in
Cost to publish: About US$7,280 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is The Lancet Oncology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q1, CiteScore 42.
What quartile is The Lancet Oncology in Scopus?
The Lancet Oncology is Q1 in Oncology (rank 8 of 428), by CiteScore 2025.
What is the impact factor of The Lancet Oncology?
The Lancet Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 42, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 9.432, quartile Q1, with an H-index of 455.
How much does it cost to publish in The Lancet Oncology?
The publisher lists an article processing charge of about US$7,280 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes The Lancet Oncology and what is its ISSN?
The Lancet Oncology is published by Elsevier Ltd. Its print ISSN is 1470-2045 and its online ISSN is 1474-5488.
Is The Lancet Oncology covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is The Lancet Oncology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is The Lancet Oncology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is The Lancet Oncology? — open metrics via OpenAlex
The Lancet Oncology has an h-index of 524 and a 2-year mean of 12.32 citations per paper (OpenAlex). Its Scopus CiteScore is 42, quartile Q1. On 2-year citations it ranks #13 of 424 Scopus journals in Oncology.
524
h-index
12.32
2-yr mean citations
4,546
i10-index
12,125
works indexed
1,071,965
total citations
Publication fee · open access list price, US$
US$7,280
2-yr mean citations, among Scopus journals in the same subject
#13 of 424 Top 4% Oncology
The Lancet Oncology published 503 papers in 2025; its busiest recent year was 2017 with 640. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in The Lancet Oncology? — latest 68 articles, 2026
In its latest 68 research articles (2026), authors are most often from United States (16.8%), United Kingdom (12.4%) and Canada (8.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for The Lancet Oncology? — indicators, not proof of misconduct
Scopus status: Active. 13 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 13 · 1.1 per 1,000 papers
- Problematic Paper Screener flags 1 · 0.1 per 1,000 papers — mostly suspect text
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
The Lancet Psychiatry Scopus Q1 WoS SCIE/SSCI The Lancet Public Health Scopus Q1 WoS SCIE/SSCI DOAJ The Lancet Regional Health - Americas Scopus Q1 WoS ESCI DOAJ The Lancet Regional Health - Europe Scopus Q1 WoS SCIE/SSCI DOAJ The Lancet Regional Health - Southeast Asia Scopus Q1 WoS ESCI DOAJ The Lancet Regional Health - Western Pacific Scopus Q1 WoS SCIE/SSCI DOAJ The Lancet Respiratory Medicine Scopus Q1 WoS SCIE The Lancet Rheumatology Scopus Q1 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.